Zennova

Zennova Pharmaceuticals Group is a high-tech international pharmaceutical company registered in the Cayman Islands, driven by innovative research and development. With its excellent product development capabilities and international reach, the company delivers superior value products to patients. The company focuses on three strategic priorities: Made in China, global R&D, and global markets, concentrating on four major therapeutic areas: ophthalmology, virology, cardiovascular, and oncology. Among these, ophthalmology and oncology are the two core strategic areas. Currently, the company has multiple innovative formulations that have entered the early stages of clinical trials in both China and the United States.The company has established R&D bases in New York, USA, and Chengdu, China. Its pharmaceutical production base located in Tianfu International Bio-Town, Chengdu, will in the future obtain certifications from the U.S. FDA, EU EMA, and Chinese GMP, reaching internationally advanced quality standards. It will produce full-range pharmaceuticals consistent with European and American quality and bioequivalence standards, including various anti-cancer drugs, sterile eye drops, and central nervous system medications, among other prescription drugs. These products will be marketed both in China and globally. The company primarily engages in the research, production, and sales of its proprietary specialty medicines. At the same time, it actively acquires distinctive products in the global premium market and undertakes contract manufacturing of high-end formulations, while comprehensively collaborating with top-tier enterprises worldwide on pharmaceutical development and production. The goal is to establish a world-class high-tech pharmaceutical enterprise based in Chengdu's High-Tech Zone.